On this page
Shawn Cross
Insider
First SEC filing: Nov. 5, 2024 · Latest: Nov. 5, 2024
Insider at
Insider transactions
0 buys (P)
7 sells (S)
Net: $-1,521,351
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| April 23, 2026 | PCRX | M | 12,941 | $16.45 | $212,879 | 118,282 Direct | +12.28% | Acquired | 50.5% (price as of 2026-10-06) |
| April 23, 2026 | PCRX | S 10b5-1 | 12,941 | $25.16 | $325,596 | 105,341 Direct | -10.94% | Disposed | -1.6% (price as of 2026-10-06) |
| April 23, 2026 | PCRX | M | 12,941 | · | · | 150,000 Direct | -7.94% | Disposed | (price as of 2026-10-06) |
| April 22, 2026 | PCRX | M | 1,500 | $16.45 | $24,675 | 106,841 Direct | +1.42% | Acquired | 50.5% (price as of 2026-10-06) |
| April 22, 2026 | PCRX | S 10b5-1 | 1,500 | $25.01 | $37,515 | 105,341 Direct | -1.40% | Disposed | -1.0% (price as of 2026-10-06) |
| April 22, 2026 | PCRX | M | 1,500 | · | · | 162,941 Direct | -0.91% | Disposed | (price as of 2026-10-06) |
| April 21, 2026 | PCRX | M | 2,845 | $16.45 | $46,800 | 108,186 Direct | +2.70% | Acquired | 50.5% (price as of 2026-10-06) |
| April 21, 2026 | PCRX | S 10b5-1 | 2,845 | $25.01 | $71,153 | 105,341 Direct | -2.63% | Disposed | -1.0% (price as of 2026-10-06) |
| April 21, 2026 | PCRX | M | 2,845 | · | · | 164,441 Direct | -1.70% | Disposed | (price as of 2026-10-06) |
| April 20, 2026 | PCRX | M | 7,714 | $16.45 | $126,895 | 113,055 Direct | +7.32% | Acquired | 50.5% (price as of 2026-10-06) |
| April 20, 2026 | PCRX | S 10b5-1 | 7,714 | $25.14 | $193,930 | 105,341 Direct | -6.82% | Disposed | -1.5% (price as of 2026-10-06) |
| April 20, 2026 | PCRX | M | 7,714 | · | · | 167,286 Direct | -4.41% | Disposed | (price as of 2026-10-06) |
| Feb. 11, 2026 | PCRX | A | 49,091 | · | · | 105,341 Direct | +87.27% | Acquired | (price as of 2026-10-06) |
| Dec. 10, 2025 | PCRX | M | 9,104 | $16.45 | $149,761 | 65,354 Direct | +16.18% | Acquired | 50.5% (price as of 2026-10-06) |
| Dec. 10, 2025 | PCRX | S 10b5-1 | 9,104 | $25.14 | $228,875 | 56,250 Direct | -13.93% | Disposed | -1.5% (price as of 2026-10-06) |
| Dec. 10, 2025 | PCRX | M | 9,104 | · | · | 175,000 Direct | -4.95% | Disposed | (price as of 2026-10-06) |
| Dec. 9, 2025 | PCRX | M | 15,896 | $16.45 | $261,489 | 72,146 Direct | +28.26% | Acquired | 50.5% (price as of 2026-10-06) |
| Dec. 9, 2025 | PCRX | S 10b5-1 | 15,896 | $25.03 | $397,877 | 56,250 Direct | -22.03% | Disposed | -1.1% (price as of 2026-10-06) |
| Dec. 9, 2025 | PCRX | M | 15,896 | · | · | 184,104 Direct | -7.95% | Disposed | (price as of 2026-10-06) |
| Nov. 10, 2025 | PCRX | S 10b5-1 | 12,060 | $22.09 | $266,405 | 56,250 Direct | -17.65% | Disposed | 12.1% (price as of 2026-10-06) |
| Oct. 31, 2025 | PCRX | F | 6,690 | $21.38 | $143,032 | 68,310 Direct | -8.92% | Disposed | 15.8% (price as of 2026-10-06) |
| Nov. 4, 2024 | PCRX | A | 200,000 | · | · | 200,000 Direct | · | Acquired | (price as of 2026-10-06) |
| Nov. 1, 2024 | PCRX | A | 75,000 | · | · | 75,000 Direct | · | Acquired | (price as of 2026-10-06) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 23, 2026 | PCRX | Stock Option (Right to Buy) | Common Stock | $16.45 | Nov. 4, 2034 | 12,941 | Disposed |
| April 22, 2026 | PCRX | Stock Option (Right to Buy) | Common Stock | $16.45 | Nov. 4, 2034 | 1,500 | Disposed |
| April 21, 2026 | PCRX | Stock Option (Right to Buy) | Common Stock | $16.45 | Nov. 4, 2034 | 2,845 | Disposed |
| April 20, 2026 | PCRX | Stock Option (Right to Buy) | Common Stock | $16.45 | Nov. 4, 2034 | 7,714 | Disposed |
| Dec. 10, 2025 | PCRX | Stock Option (Right to Buy) | Common Stock | $16.45 | Nov. 4, 2034 | 9,104 | Disposed |
| Dec. 9, 2025 | PCRX | Stock Option (Right to Buy) | Common Stock | $16.45 | Nov. 4, 2034 | 15,896 | Disposed |
| Nov. 4, 2024 | PCRX | Stock Option (Right to Buy) | Common Stock | $16.45 | Nov. 4, 2034 | 200,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).